OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults
Luis Pérez de Llano, Ghislaine Scélo, Trung N. Tran, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 7, pp. 869-880
Open Access | Times Cited: 28
Luis Pérez de Llano, Ghislaine Scélo, Trung N. Tran, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 7, pp. 869-880
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Marc A. Gauthier, Sagar Kale, Anuradha Ray
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
Non-T2 asthma
Emily K. Duffus, Fernando Holguin, Deepa Rastogi
Current Opinion in Pulmonary Medicine (2025)
Closed Access | Times Cited: 1
Emily K. Duffus, Fernando Holguin, Deepa Rastogi
Current Opinion in Pulmonary Medicine (2025)
Closed Access | Times Cited: 1
Remission in the World of Severe Asthma
Ian Pavord
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 7, pp. 855-857
Closed Access | Times Cited: 5
Ian Pavord
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 7, pp. 855-857
Closed Access | Times Cited: 5
Achieving sustained remission in severe asthma: goals, challenges, issues and opportunities
Alessandro Vatrella, Angelantonio Maglio
Expert Review of Respiratory Medicine (2025)
Closed Access
Alessandro Vatrella, Angelantonio Maglio
Expert Review of Respiratory Medicine (2025)
Closed Access
Roads to remission: evolving treatment concepts in type 2 inflammatory diseases
Marek Lommatzsch, Katharina Blümchen, Lisa A. Beck, et al.
EClinicalMedicine (2025) Vol. 80, pp. 103050-103050
Open Access
Marek Lommatzsch, Katharina Blümchen, Lisa A. Beck, et al.
EClinicalMedicine (2025) Vol. 80, pp. 103050-103050
Open Access
Biologics in severe asthma: a state-of-the-art review
Bishal Gyawali, Steve N. Georas, Sandhya Khurana
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240088-240088
Open Access
Bishal Gyawali, Steve N. Georas, Sandhya Khurana
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240088-240088
Open Access
Trajectories of responses to mepolizumab in severe asthma
Santi Nolasco, Manali Mukherjee, Parameswaran Nair
European Respiratory Journal (2025) Vol. 65, Iss. 1, pp. 2402023-2402023
Closed Access
Santi Nolasco, Manali Mukherjee, Parameswaran Nair
European Respiratory Journal (2025) Vol. 65, Iss. 1, pp. 2402023-2402023
Closed Access
Clinical Remission of Mild-to-Moderate Asthma: Rates, Contributing Factors, and Stability
Mana Ishizuka, Naoya Sugimoto, Konomi Kobayashi, et al.
Journal of Allergy and Clinical Immunology Global (2025), pp. 100431-100431
Open Access
Mana Ishizuka, Naoya Sugimoto, Konomi Kobayashi, et al.
Journal of Allergy and Clinical Immunology Global (2025), pp. 100431-100431
Open Access
Reply to: Response and remission in asthma with tezepelumab: overlapping concepts informing on type-2 inflammatory-dependent treatment effects
Neil Martin, Michael E. Wechsler, Christopher E. Brightling
European Respiratory Journal (2025) Vol. 65, Iss. 2, pp. 2402434-2402434
Open Access
Neil Martin, Michael E. Wechsler, Christopher E. Brightling
European Respiratory Journal (2025) Vol. 65, Iss. 2, pp. 2402434-2402434
Open Access
WHAT WE KNOW TO DATE ABOUT EARLY TREATMENT WITH BIOLOGICS IN SEVERE ASTHMA
Luis Pérez de Llano, Mary Ann Bonilla, Elisa Luzón, et al.
Open Respiratory Archives (2025) Vol. 7, Iss. 2, pp. 100418-100418
Open Access
Luis Pérez de Llano, Mary Ann Bonilla, Elisa Luzón, et al.
Open Respiratory Archives (2025) Vol. 7, Iss. 2, pp. 100418-100418
Open Access
Advancing patient-centred care in measuring response to biologics in severe asthma
Vanesa Bellou
European Respiratory Journal (2025) Vol. 65, Iss. 3, pp. 2402113-2402113
Closed Access
Vanesa Bellou
European Respiratory Journal (2025) Vol. 65, Iss. 3, pp. 2402113-2402113
Closed Access
Con: clinical remission in asthma – not yet there
L. Eggert, Sarah L Rhoads, Michael E. Wechsler, et al.
European Respiratory Review (2025) Vol. 34, Iss. 176, pp. 240182-240182
Open Access
L. Eggert, Sarah L Rhoads, Michael E. Wechsler, et al.
European Respiratory Review (2025) Vol. 34, Iss. 176, pp. 240182-240182
Open Access
Approaches to reduce the risk of severe asthma in children with preschool wheeze
Andrew Bush, Bianca Schaub
Expert Review of Respiratory Medicine (2025)
Closed Access
Andrew Bush, Bianca Schaub
Expert Review of Respiratory Medicine (2025)
Closed Access
Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study
Piotr Damiański, Adam Białas, Marta Kołacińska-Flont, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 887-887
Open Access
Piotr Damiański, Adam Białas, Marta Kołacińska-Flont, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 887-887
Open Access
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study
Claudia Crimi, Santi Nolasco, Alberto Noto, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 12, pp. 3315-3327
Open Access | Times Cited: 4
Claudia Crimi, Santi Nolasco, Alberto Noto, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 12, pp. 3315-3327
Open Access | Times Cited: 4
Identifying Super-Responders: a Review of the Road to Asthma Remission
Samuel Mailhot-Larouche, C.A. Celis-Preciado, Liam G. Heaney, et al.
Annals of Allergy Asthma & Immunology (2024)
Open Access | Times Cited: 4
Samuel Mailhot-Larouche, C.A. Celis-Preciado, Liam G. Heaney, et al.
Annals of Allergy Asthma & Immunology (2024)
Open Access | Times Cited: 4
Towards the integrated care of COPD, asthma and bronchiectasis: description and objectives of a treatable trait-based complex obstructive airway disease unit
Borja G. Cosío, Alexandre Palou, Meritxell López, et al.
Expert Review of Respiratory Medicine (2025)
Closed Access
Borja G. Cosío, Alexandre Palou, Meritxell López, et al.
Expert Review of Respiratory Medicine (2025)
Closed Access
Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST)
Riyad Al‐Lehebi, Mona Al‐Ahmad, Venkata Nagarjuna Maturu, et al.
Advances in Therapy (2024) Vol. 41, Iss. 11, pp. 4008-4031
Open Access | Times Cited: 3
Riyad Al‐Lehebi, Mona Al‐Ahmad, Venkata Nagarjuna Maturu, et al.
Advances in Therapy (2024) Vol. 41, Iss. 11, pp. 4008-4031
Open Access | Times Cited: 3
The Bronchodilator and Anti‐Inflammatory Effect of Long‐Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper
Ioana Agache, Ian M. Adcock, Cezmi A. Akdiş, et al.
Allergy (2024) Vol. 80, Iss. 2, pp. 380-394
Closed Access | Times Cited: 3
Ioana Agache, Ian M. Adcock, Cezmi A. Akdiş, et al.
Allergy (2024) Vol. 80, Iss. 2, pp. 380-394
Closed Access | Times Cited: 3
Stepping down biologics in asthma: is it time to challenge the status quo?
Sandhya Khurana, Steve N. Georas
European Respiratory Journal (2024) Vol. 64, Iss. 2, pp. 2401168-2401168
Closed Access | Times Cited: 1
Sandhya Khurana, Steve N. Georas
European Respiratory Journal (2024) Vol. 64, Iss. 2, pp. 2401168-2401168
Closed Access | Times Cited: 1
Triple inhaled therapy in asthma: beliefs, behaviours and doubts.
Diego Bagnasco, Ignacio J. Ansotegui, I. Baiardini, et al.
Pulmonary Pharmacology & Therapeutics (2024), pp. 102333-102333
Open Access | Times Cited: 1
Diego Bagnasco, Ignacio J. Ansotegui, I. Baiardini, et al.
Pulmonary Pharmacology & Therapeutics (2024), pp. 102333-102333
Open Access | Times Cited: 1
Use of High-Dose Inhaled Corticosteroids and Risk of Corticosteroid Related Adverse Events in Asthma - Findings from the NORDSTAR Cohort
Anna von Bülow, Susanne Hansen, Patrik Sandin, et al.
(2024)
Closed Access
Anna von Bülow, Susanne Hansen, Patrik Sandin, et al.
(2024)
Closed Access
Role of Thymic Stromal Lymphopoietin in the Pathophysiology of Asthma and Clinical and Biological Effects of Blockade With Tezepelumab
C. Venegas Garrido, Parameswaran Nair, Ignacio Dávila, et al.
Journal of Investigational Allergology and Clinical Immunology (2024) Vol. 34, Iss. 5, pp. 293-302
Open Access
C. Venegas Garrido, Parameswaran Nair, Ignacio Dávila, et al.
Journal of Investigational Allergology and Clinical Immunology (2024) Vol. 34, Iss. 5, pp. 293-302
Open Access
Biologics in Asthma
Brinda Desai, Muhammad Adrish, Arjun Mohan, et al.
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 751-763
Closed Access
Brinda Desai, Muhammad Adrish, Arjun Mohan, et al.
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 751-763
Closed Access
Biologics in Asthma
Orlando E. Rivera, Rohit Katial, Flavia Hoyte
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 725-736
Closed Access
Orlando E. Rivera, Rohit Katial, Flavia Hoyte
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 725-736
Closed Access
